| abstract |
The invention provides compositions and methods for the treatment of amyloidogenic diseases. Such methods represent the administration of an agent that induces a beneficial immune response to amyloid deposition in a patient. The methods are particularly useful for the prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, the suitable (appropriate) agent is an Aβ-peptide or an antibody to it. |